Annual Long Term Debt
$208.08 M
+$2.84 M+1.38%
December 31, 2023
Summary
- As of February 8, 2025, INBX annual long term debt is $208.08 million, with the most recent change of +$2.84 million (+1.38%) on December 31, 2023.
- During the last 3 years, INBX annual long term debt has risen by +$172.13 million (+478.78%).
- INBX annual long term debt is now at all-time high.
Performance
INBX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, INBX quarterly long term debt is $0.00, unchanged on September 30, 2024.
- Over the past year, INBX quarterly long term debt has stayed the same.
- INBX quarterly long term debt is now -100.00% below its all-time high of $207.37 million, reached on September 30, 2023.
Performance
INBX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
INBX Long Term Debt Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.4% | 0.0% |
3 y3 years | +478.8% | -100.0% |
5 y5 years | +5740.0% | -100.0% |
INBX Long Term Debt Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +175.6% | -100.0% | at low |
5 y | 5-year | at high | +478.8% | -100.0% | at low |
alltime | all time | at high | +5740.0% | -100.0% | at low |
Inhibrx Biosciences Long Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $0.00(0.0%) |
Jun 2024 | - | $0.00(-100.0%) |
Mar 2024 | - | $561.00 K(-49.5%) |
Dec 2023 | $208.08 M(+1.4%) | $1.11 M(-99.5%) |
Sep 2023 | - | $207.37 M(+0.3%) |
Jun 2023 | - | $206.65 M(+0.3%) |
Mar 2023 | - | $205.94 M(+0.3%) |
Dec 2022 | $205.24 M(+171.8%) | $205.24 M(+17.6%) |
Sep 2022 | - | $174.48 M(+0.3%) |
Jun 2022 | - | $173.93 M(+52.9%) |
Mar 2022 | - | $113.73 M(+50.6%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $75.50 M(+110.0%) | $75.50 M(-0.0%) |
Sep 2021 | - | $75.54 M(-0.0%) |
Jun 2021 | - | $75.57 M(+111.4%) |
Mar 2021 | - | $35.75 M(-0.6%) |
Dec 2020 | $35.95 M(-3.0%) | $35.95 M(+266.1%) |
Sep 2020 | - | $9.82 M(+5.0%) |
Jun 2020 | - | $9.36 M(-74.8%) |
Dec 2019 | $37.06 M(+940.3%) | $37.06 M(+13.2%) |
Jun 2019 | - | $32.75 M(+334.4%) |
Mar 2019 | - | $7.54 M |
Dec 2018 | $3.56 M(-62.5%) | - |
Dec 2017 | $9.49 M | - |
FAQ
- What is Inhibrx Biosciences annual long term debt?
- What is the all time high annual long term debt for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual long term debt year-on-year change?
- What is Inhibrx Biosciences quarterly long term debt?
- What is the all time high quarterly long term debt for Inhibrx Biosciences?
- What is Inhibrx Biosciences quarterly long term debt year-on-year change?
What is Inhibrx Biosciences annual long term debt?
The current annual long term debt of INBX is $208.08 M
What is the all time high annual long term debt for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual long term debt is $208.08 M
What is Inhibrx Biosciences annual long term debt year-on-year change?
Over the past year, INBX annual long term debt has changed by +$2.84 M (+1.38%)
What is Inhibrx Biosciences quarterly long term debt?
The current quarterly long term debt of INBX is $0.00
What is the all time high quarterly long term debt for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly long term debt is $207.37 M
What is Inhibrx Biosciences quarterly long term debt year-on-year change?
Over the past year, INBX quarterly long term debt has changed by $0.00 (0.00%)